Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
82,244 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Sep 30, 2026 | AmeriHealth | Percutaneous Coronary Intervention, Coronary Angiography, and Arterial UltrasoundPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-113N-21C2C55945 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Pembrolizumab and berahyaluronidase alfa-pmph (KEYTRUDA QLEX)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-189A-CA24F3693A | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Pembrolizumab (Keytruda)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-121F-0B1ADFE369 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Outpatient Physical Medicine and Rehabilitation Services- Physical Therapy (PT) and Occupational Therapy (OT)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA10-003J-D11141A12A | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Otoplasty or Non-Surgical External Ear MoldingPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-058A-E49D2A7377 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Orthognathic SurgeryPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-083A-CB7287558D | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Ocrelizumab (Ocrevus) and Ocrelizumab and Hyaluronidase-ocsq (Ocrevus Zunovo)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-088E-34BF4BA987 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Nusinersen (Spinraza)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-086D-54F9058120 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Non-Spinal Osteogenic Stimulators (Electrical and Ultrasonic)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-018D-CF394E4F91 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Nivolumab (Opdivo), Nivolumab and Hyaluronidase-nvhy (Opdivo Qvantig)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-120G-E40D29927E | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Neuropsychological Testing for Neurologically Based ConditionsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-038K-1A6082FE77 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Musculoskeletal ServicesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA00-047T-3F39C24AB1 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Multiple Surgery Payment ReductionPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-032H-91D1904680 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Mogamulizumab-kpkc (Poteligeo)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-102G-5A52F34C14 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Modifiers 26 (Professional Component) and TC (Technical Component)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA03-011O-423A90A409 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Medicare Part B vs. Part D Crossover DrugsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-007AW-791410F6C9 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Medical NecessityPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA12-008C-B7E7CA6D46 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Measurement of Serum Antibodies to and Measurement of Serum Levels of BiologicsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA06-019C-B4C0D76708 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Lumasiran (Oxlumo)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-131C-4A88263B5B | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Laser Interstitial Thermal Therapy (LITT)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-034-D0666C1800 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Lanreotide (Somatuline Depot)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-090H-798433DB5E | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Laboratory Services for Members Enrolled in Health Maintenance Organization (HMO) or Health Maintenance Organization Point-of-Service (HMO-POS) ProductsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA00-030AK-8EE5ED6B56 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Intravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Antagonists, VEGF Biosimilars, and Combination VEGF/Angiopoietin-2 (Ang-2) InhibitorsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-073V-ED34BE7CDB | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | High-Technology Radiology ServicesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA09-002AH-635D3E519C | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Facility Reporting of Observation ServicesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA00-040B-44F8E78709 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | eviCore Lab ManagementPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA06-034U-B4BD9C1778 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Endoscopic Submucosal Dissection (ESD)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-118-1F3BB60FBF | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Durvalumab (Imfinzi) and Tremelimumab-actl (Imjudo)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-123E-C351A28D4E | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Day RehabilitationPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA10-005C-A01E88E73C | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Daratumumab (Darzalex), Daratumumab and Hyaluronidase-fihj (Darzalex Faspro)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-079M-7D0D371D48 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Corneal Pachymetry Using UltrasoundPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-046H-BAA5AA495A | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Care Management and Care Planning ServicesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA00-006P-C8C9975690 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Bioimpedance for the Detection of LymphedemaPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-052A-48ADA05C01 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Atezolizumab (Tecentriq) and Atezolizumab with Hyaluronidase-tqjs (Tecentriq Hybreza)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-127F-7F5FC3D7DA | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Aqueous Shunts, Microstents, Viscocanalostomy, and Canaloplasty for the Treatment of GlaucomaPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-105K-FB14E7269D | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Alemtuzumab (Lemtrada)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-015E-2AECB00C21 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Acute Care Facility Inpatient TransfersPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA12-003B-E0F622FFAA | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Ustekinumab for Intravenous InfusionPayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-82Q-344348E2F7 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Treatments for Complex Regional Pain Syndrome (CRPS)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-57V-BB8AE1D715 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Tocilizumab and Related Biosimilars for Intravenous InfusionPayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-85T-0EF19283B0 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Tildrakizumab-asmn (Ilumya)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-48B-331266F9C8 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Therapies for Spinal Muscular Atrophy Nusinersen (Spinraza) and Onasemnogene abeparvovec-xioi (Zolgensma)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-36H-3CFA7A4C1A | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)PayerPolicy · AMERIHEALTH-COMMERCIAL-11-17-06W-1239F67146 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Steroid-Eluting Sinus Stents and ImplantsPayerPolicy · AMERIHEALTH-COMMERCIAL-11-16-08F-F146EE5AEE | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Sleep Disorder Testing and Positive Airway Pressure Therapy Services and SuppliesPayerPolicy · AMERIHEALTH-COMMERCIAL-07-03-05AB-273C9EF5E3 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Short-term Interstitial Continuous Glucose Monitoring Systems (CGMS)PayerPolicy · AMERIHEALTH-COMMERCIAL-05-00-24S-CE8E91380C | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Remote Electrical Neuromodulation for MigrainesPayerPolicy · AMERIHEALTH-COMMERCIAL-05-00-86-E5E0282766 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Psychiatric Collaborative Care Management (CoCM) (AmeriHealth)PayerPolicy · AMERIHEALTH-COMMERCIAL-00-01-70B-40F13CBB0E | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | PPO Network Rules for Provision of Specialty Services for Durable Medical Equipment and Laboratory, Radiology, and Physical Medicine and Rehabilitative ServicesPayerPolicy · AMERIHEALTH-COMMERCIAL-00-01-25BU-1B58405CF5 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | PPO Network Rules for Provision of Specialty Services for Durable Medical Equipment and Laboratory, Radiology, and Physical Medicine and Rehabilitative ServicesPayerPolicy · AMERIHEALTH-COMMERCIAL-00-01-25BT-A6EC61B207 | Retired |
|---|